Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

CCRM Uses ambr15 for Pluripotent Stem Cell Expansion

Published: Tuesday, August 05, 2014
Last Updated: Tuesday, August 05, 2014
Bookmark and Share
New protocols increase stem cell expansion outputs and improve differentiation into cardiomyocytes.

TAP Biosystems has announced that the ambr15™ micro bioreactor system is being used at the Centre for Commercialization of Regenerative Medicine (CCRM), Canada to rapidly develop methods for culturing stem cells in bioreactors, thus shortening timelines for successfully scaling-up and manufacturing more cost-effective cell therapies and regenerative medicines.

Scientists at CCRM have utilized the ambr15 micro bioreactor system to optimize methods for forming three-dimensional aggregates of pluripotent stem cells (PSCs) for cell expansion, and differentiating the aggregates into enriched cardiomyocytes populations.

In the new protocol for PSC aggregate culture, PSCs were incubated in media supplemented with FGF-2 and ROCKi, in six well plates on orbital shakers for 24 hours. The cell suspensions were transferred to ambr15 micro bioreactors or left on the orbital shakers where they were incubated for a further 48 hours.

Different agitation speeds of 300rpm or 600rpm were set for the ambr15 micro bioreactors and 70rpm for the controls. The results showed that cells cultured in the ambr15 micro bioreactors produced aggregates of a more consistent size distribution with greater total cell expansion compared to controls. Preliminary data indicate using ambr15 micro bioreactors to optimize parameters, such as agitation speed, could improve cell yield for PSC culture.

For differentiation, PSCs in ambr15 micro bioreactors were induced to cardiac cells over 14 days. The results showed that culture in the ambr15 significantly improved cardiomyocyte yield compared to the orbital shaker controls.

“These preliminary data provide promising leads on key parameters for further optimization of pluripotent stem cell culture and production of cardiomyocytes," explains Dr. Nick Timmins, Director Product and Process Development, Centre for Commercialization of Regenerative Medicine. "The ambr has been instrumental in enabling rapid translation of these cultures to controlled bioreactors, and lays the foundations for successful scale-up to clinically meaningful cell quantities in the future."

The full methods and results of the CCRM studies are available in a poster that can be requested via the link: http://www.tapbiosystems.com/tap/cell_culture/ambr15_poster.asp.

Dr Barney Zoro, ambr Product Manager at TAP Biosystems stated: "A challenge for the regenerative medicine industry is to develop cell culture processes that are well characterized and can be scaled up for production to ensure clinical and commercial success. Producing PSC aggregates is one example of how to culture non-adherent stem cells in bioreactors to enable generation of clinical scale cell yields.”

Zoro continued: “The research by the CCRM scientists with the ambr15 is very exciting because it shows that this technology not only allows modelling of stem cell expansion and differentiation but also optimization of stem cell related parameters. Utilizing ambr15 for these applications reduces reliance on costly and time consuming bench top bioreactors, allowing cell therapy scientists to reduce costs and timelines for their process development work. This will help them develop robust, cost-effective manufacturing processes and means affordable regenerative therapies for large patient numbers could become a reality.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

TAP Biosystems Presents New Data on 3D Cell Culture Research
Discussing the application of RAFT 3D models in oncology, toxicology and neuroscience cell-based screening programmes.
Monday, January 20, 2014
Scientific News
Manufactured Stem Cells To Advance Clinical Research
Clinical-grade cell line will enable development of new therapies and accelerate early-stage clinical research.
Manufactured Stem Cells to Advance Clinical Research
Clinical-grade cell line will enable development of new therapies and accelerate early-stage clinical research.
Starving Stem Cells May Enable Scientists To Build Better Blood Vessels
Researchers from the University of Illinois at Chicago College of Medicine have uncovered how changes in metabolism of human embryonic stem cells help coax them to mature into specific cell types — and may improve their function in engineered organs or tissues.
Long-Term Culturing of Adult Stem Cells
A new procedure developed by Harvard Stem Cell Institute researchers (HSCI) at Massachusetts General Hospital (MGH) may revolutionize the culturing of adult stem cells.
Naked Mole Rat Exhibits “Extraordinary” Cancer Resistance
Scientists are getting closer to understanding the anti-cancer mechanism of the naked mole rat by making induced pluripotent stem cells.
Solutions for Biotherapeutic Characterization
Innovation to speed the routine.
Reclaiming The Immune System's Assault On Tumors
EPFL study shows a way to reclaim corrupted immune cells.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Body’s Own Gene Editing System Generates Leukemia Stem Cells
Inhibiting the editing enzyme may provide a new therapeutic approach for blood cancers.
Cirrhosis-Causing Cells Converted to Healthy Liver Cells in Mice
New approach that repairs liver from within may be more efficient than cell transplants.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!